Glycemic Response to Road Cycling in Type 1 Diabetes
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2011 by Team Type 1, Inc..
Recruitment status was Active, not recruiting
Information provided by:
Team Type 1, Inc.
First received: July 19, 2011
Last updated: July 20, 2011
Last verified: July 2011
The purpose of this study is to assess the glycemic response to cycling road races (using continuous glucose monitoring ) in elite athletes with type 1 diabetes and non-diabetic controls. The investigators will also assess the relationship between power/work during cycling (using a power meter) and the subject's glucose profile.
||Observational Model: Case Control
Time Perspective: Prospective
||A Pilot Study Assessing the Glycemic Response and Its Relationship to Performance During Road Cycling in Elite Athletes With Type 1 Diabetes and Non-Diabetic Controls
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||August 2011 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||18 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Professional cyclists on TeamType 1 cycling teams
- ≥18 years of age
- A1C ≤8.0% if diagnosed with type 1 DM
- If diagnosed with type 1 diabetes, has had recurrent severe hypoglycemia (greater than 2 episodes in previous 6 months requiring assistance by a third party)
- Has any medical condition or medical history that may affect successful completion of the study and/or personal well-being (as assessed by the PI)
Please refer to this study by its ClinicalTrials.gov identifier: NCT01398826
Team Type 1, Inc.
||Juan P Frias, MD
||Team Type 1, Inc.
No publications provided
||Juan Pablo Frias, MD, TeamType 1
History of Changes
|Other Study ID Numbers:
|Study First Received:
||July 19, 2011
||July 20, 2011
||United States: Institutional Review Board
Keywords provided by Team Type 1, Inc.:
Type 1 Diabetes
Continuous glucose monitoring
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on April 17, 2014
Diabetes Mellitus, Type 1
Glucose Metabolism Disorders
Endocrine System Diseases
Immune System Diseases